Flu and Pneumonia Vaccine Benefits in COPD Patients
Part of Infections, Lungs & breathing clinical trials.
This study looks at whether flu and pneumonia vaccines are worth the cost and effort for people with COPD (chronic lung disease). Researchers will track how often vaccinated patients get sick and how much healthcare they use, compared to unvaccinated patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with COPD (chronic obstructive pulmonary disease) confirmed by a breathing test showing reduced airflow
- You are between 45 and 80 years old
- You do not have other lung diseases like bronchiectasis, tuberculosis scars, or a history of lung surgery
- You do not have lung cancer
- You are not pregnant, breastfeeding, or planning to become pregnant in the next year
- You have not received a pneumococcal vaccine (23-valent) in the last 5 years
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood markers (special proteins) in patients who have had both a heart attack and pneumonia, to see how vaccination affects recovery. The goal is to understand whether flu and pneumonia vaccines are safe and helpful for people recovering from these two serious conditions together.
This study tests a pneumococcal vaccine designed for 20 types of bacteria in older adults who are hospitalized with suspected community-acquired pneumonia. It aims to see how the vaccine works in real-world care and whether it affects how pneumonia happens or progresses.
This study tests whether treating a specific germ (Pneumocystis jirovecii) in the lungs can reduce the number of COPD flare-ups. If you have COPD with frequent flare-ups and this germ is found in your sputum, you may benefit.
This study looks at how your lungs and lymph nodes respond to flu infection and the nasal flu vaccine. It will help researchers understand how to create better protection against the flu.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
This trial tests whether a pneumococcal vaccine can help protect against a specific type of pneumonia bacteria. Researchers want to see if the vaccine can create antibodies that work against multiple strains.
Hear when a new Influenza and Pneumonia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.